American Association for Cancer Research
Browse
00085472can143613-sup-141787_2_supp_2957361_nnklst.pdf (112.55 kB)

Supplementary Figure 7 from CASC15-S Is a Tumor Suppressor lncRNA at the 6p22 Neuroblastoma Susceptibility Locus

Download (112.55 kB)
journal contribution
posted on 2023-03-30, 23:03 authored by Mike R. Russell, Annalise Penikis, Derek A. Oldridge, Juan R. Alvarez-Dominguez, Lee McDaniel, Maura Diamond, Olivia Padovan, Pichai Raman, Yimei Li, Jun S. Wei, Shile Zhang, Janahan Gnanchandran, Robert Seeger, Shahab Asgharzadeh, Javed Khan, Sharon J. Diskin, John M. Maris, Kristina A. Cole

Depletion of the long isoform of CASC15 does not impact neuroblastoma cell viability.

History

ARTICLE ABSTRACT

Chromosome 6p22 was identified recently as a neuroblastoma susceptibility locus, but its mechanistic contributions to tumorigenesis are as yet undefined. Here we report that the most highly significant single-nucleotide polymorphism (SNP) associations reside within CASC15, a long noncoding RNA that we define as a tumor suppressor at 6p22. Low-level expression of a short CASC15 isoform (CASC15-S) associated highly with advanced neuroblastoma and poor patient survival. In human neuroblastoma cells, attenuating CASC15-S increased cellular growth and migratory capacity. Gene expression analysis revealed downregulation of neuroblastoma-specific markers in cells with attenuated CASC15-S, with concomitant increases in cell adhesion and extracellular matrix transcripts. Altogether, our results point to CASC15-S as a mediator of neural growth and differentiation, which impacts neuroblastoma initiation and progression. Cancer Res; 75(15); 3155–66. ©2015 AACR.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC